ALPINE IMMUNE SCIENCES, INC. Increase (Decrease) in Accrued Liabilities
ALPINE IMMUNE SCIENCES, INC. reported Increase (Decrease) in Accrued Liabilities of $1.08 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2019-05-09
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-03-31 was $1.08M, a 428.92% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-12-31 was -$37.00K.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-09-30 was $3.73M.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-06-30 was -$1.00K, a 100.24% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2018 was $3.90M.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2017 was -$259.00K, a 764.10% decline from fiscal 2016.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2016 was $39.00K, a 77.84% decline from fiscal 2015.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2015 was $176.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2019-03-31 | $1.08M 10-Q · filed 2019-05-09 | $1.04M derived: sum of 2 quarters · filed 2019-05-09 | $4.77M derived: sum of 3 quarters · filed 2019-05-09 | $4.77M derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $3.69M derived: sum of 2 quarters · filed 2019-03-18 | $3.69M derived: sum of 3 quarters · filed 2019-03-18 | $3.90M 10-K · filed 2019-03-18 |
| 2018-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.73M derived: sum of 2 quarters · filed 2018-11-08 | $3.93M 10-Q · filed 2018-11-08 | $3.59M derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $203.00K 10-Q · filed 2018-08-09 | -$138.00K derived: sum of 3 quarters · filed 2019-05-09 | -$887.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-03-31 | $204.00K 10-Q · filed 2019-05-09 | -$137.00K derived: sum of 2 quarters · filed 2019-05-09 | -$886.00K derived: sum of 3 quarters · filed 2019-05-09 | -$461.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$341.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$1.09M derived: sum of 2 quarters · filed 2019-03-18 | -$665.00K derived: sum of 3 quarters · filed 2019-03-18 | -$259.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | -$749.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$324.00K derived: sum of 2 quarters · filed 2018-11-08 | $82.00K 10-Q · filed 2018-11-08 | $111.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $425.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $831.00K 10-Q · filed 2018-08-09 | $860.00K derived: sum of 3 quarters · filed 2019-03-18 | |
| 2017-03-31 | $406.00K 10-Q · filed 2018-05-14 | $435.00K derived: sum of 2 quarters · filed 2019-03-18 | ||
| 2016-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $39.00K 10-K · filed 2019-03-18 | ||
| 2016-09-30 | $10.00K 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $176.00K 10-K · filed 2018-03-28 |